In CCM, elevated plasma levels of IL-1β, IL-2, IFN-γ and TNF-α have been associated with disease activity [11, 33], probably by activating the MEKK3-KLF2/4 pathway [8, 9]. This evidence concerns the gene IL2 and cerebral cavernous malformation.